Protein-Binding Ligand Screening by Ribosome Display
TypeName: Business Offer
Category:
Offer Date:2019/04/05
Country: United States
Summary: Creative Biolabs has developed the in vitro display system for screening ligands from large libraries. The company can use the ribosome display technology to screen peptides binding to the antibody (antigen epitope), or other proteins from very large combinatorial peptide libraries (As large as 1012-1014). We have extensive experience to generate high-quality antibody libraries, which can largely accelerate the in vitro display process. https://www.creative-biolabs.com/protein-binding-ligand-screening-by-ribosome-display.html